Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6125638 | Osteoarthritis and Cartilage | 2010 | 6 Pages |
Abstract
This study strengthens the premise that OPG might be a valid biomarker of hand OA. Confirmation of these results in larger cohorts of patients will reinforce our theory that the RANKL/OPG pathway is a suitable target for developing novel agents against OA.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
I. Pantsulaia, L. Kalichman, E. Kobyliansky,